ZYDUSLIFE.NS Zydus Lifesciences Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 1291738 | 687797 | 53.25% |
| 2026-08-27 | 3168135 | 1572472 | 49.63% |
| 2026-08-26 | 1401027 | 733873 | 52.38% |
| 2026-08-25 | 1152463 | 576173 | 49.99% |
| 2026-08-24 | 857487 | 432123 | 50.39% |
| 2026-08-21 | 1005818 | 519535 | 51.65% |
| 2026-08-20 | 987960 | 521259 | 52.76% |
| 2026-08-19 | 1255247 | 722906 | 57.59% |
| 2026-08-18 | 810133 | 460941 | 56.90% |
| 2026-08-17 | 1927424 | 1093421 | 56.73% |
| 2026-08-14 | 804336 | 366758 | 45.60% |
| 2026-08-13 | 1606705 | 813315 | 50.62% |
| 2026-08-12 | 4567528 | 2209528 | 48.37% |
| 2026-08-11 | 8187351 | 2156278 | 26.34% |
| 2026-08-10 | 932417 | 532641 | 57.12% |
| 2026-08-07 | 666151 | 368835 | 55.37% |
| 2026-08-06 | 596998 | 392985 | 65.83% |
| 2026-08-05 | 1051304 | 608928 | 57.92% |
| 2026-08-04 | 1085433 | 592405 | 54.58% |
| 2026-08-03 | 1420266 | 387081 | 27.25% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers ZYDUSLIFE.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 17 Nov 2025 | Jasodaben Babubhai Patel | Promoter Group | Buy | Market Purchase | 1000 | 963522 | 0.00% | XBRL |
| 29 Mar 2024 | DEVAL DHIRAJBHAI SHAH | Immediate relative | Sell | Market Sale | 292 | 293939 | 0.00% | XBRL |
| 29 Mar 2024 | DEVAL DHIRAJBHAI SHAH | Immediate relative | Pledge Revoke | Revokation of Pledge | 292 | 293533 | 0.00% | XBRL |
| 29 Mar 2024 | ZYDUS FAMILY TRUST | Promoters | Sell | Market Sale | 10000 | 10066755 | 74.97% | XBRL |
| 29 Mar 2024 | ZYDUS FAMILY TRUST | Promoters | Sell | Market Sale | 30000 | 30318581 | 74.96% | XBRL |
| 28 Mar 2024 | DEVAL DHIRAJBHAI SHAH | Immediate relative | Pledge | Pledge Creation | 942 | 941529 | 0.00% | XBRL |
| 28 Mar 2024 | DEVAL DHIRAJBHAI SHAH | Immediate relative | Pledge Revoke | Revokation of Pledge | 500 | 499750 | 0.00% | XBRL |
| 28 Mar 2024 | DEVAL DHIRAJBHAI SHAH | Immediate relative | Sell | Market Sale | 500 | 492785 | 0.00% | XBRL |
| 28 Mar 2024 | DEVAL DHIRAJBHAI SHAH | Immediate relative | Sell | Market Sale | 150 | 151638 | 0.00% | XBRL |
| 28 Mar 2024 | DEVAL DHIRAJBHAI SHAH | Immediate relative | Pledge Revoke | Revokation of Pledge | 150 | 152715 | 0.00% | XBRL |
| 28 Mar 2024 | ZYDUS FAMILY TRUST | Promoters | Sell | Market Sale | 17534 | 17803106 | 75.02% | XBRL |
| 28 Mar 2024 | ZYDUS FAMILY TRUST | Promoters | Sell | Market Sale | 565466 | 570362099 | 74.97% | XBRL |
| 27 Mar 2024 | HARSHA JYOTINDRA GOR | Immediate relative | Sell | Market Sale | 1000 | 1009074 | 0.00% | XBRL |
| 22 Mar 2024 | Vishal J. Gor | - | Sell | Market Sale | 862 | 832676 | 0.00% | XBRL |
| 19 Mar 2024 | Sheetal Rajan Navani | Immediate relative | Sell | Others | 799 | 802995 | 0.01% | XBRL |
| 19 Mar 2024 | Nitin Raojibhai Desai HUF | Other | Sell | Others | 460 | 462300 | 0.01% | XBRL |
| 19 Mar 2024 | Desons Holdings and Finance Private Limited | Other | Sell | Others | 10145 | 10195725 | 0.20% | XBRL |
| 19 Mar 2024 | Nitin Raojibhai Desai | Director | Sell | Others | 1926 | 1935630 | 0.04% | XBRL |
| 19 Mar 2024 | Kruti Mukesh Patel | Immediate relative | Sell | Others | 62 | 62310 | 0.00% | XBRL |
| 19 Mar 2024 | Jigar Mukesh Patel | Immediate relative | Sell | Others | 140 | 140700 | 0.00% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers ZYDUSLIFE.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
No persistent gap detected
Net Profit CAGR 2.95% vs CFO CAGR 0.46% over 4.0y (2022-03-31 → 2026-03-31); most recent year: Net Profit +3326.24% vs CFO -68.77%
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5,533.80 Cr. | ₹6,207.50 Cr. | ₹5,237.00 Cr. | ₹5,269.10 Cr. | ₹6,527.90 Cr. | ₹6,573.70 Cr. | ₹6,123.20 Cr. | ₹6,864.50 Cr. | ₹7,587.00 Cr. | ₹8,017.00 Cr. | RevenueFromOperations |
| Net Profit | ₹63.80 Cr. incl. minority ₹1,246.10 Cr. | ₹1,419.90 Cr. incl. minority ₹1,482.50 Cr. | ₹911.20 Cr. incl. minority ₹920.20 Cr. | ₹1,023.50 Cr. incl. minority ₹1,026.20 Cr. | ₹72.80 Cr. incl. minority ₹1,243.70 Cr. | ₹1,466.80 Cr. incl. minority ₹1,521.00 Cr. | ₹1,258.60 Cr. incl. minority ₹1,238.60 Cr. | ₹1,042.10 Cr. incl. minority ₹1,022.90 Cr. | ₹1,272.50 Cr. incl. minority ₹1,341.00 Cr. | ₹939.80 Cr. incl. minority ₹990.20 Cr. | ProfitOrLossAttributableToOwnersOfParent |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers ZYDUSLIFE.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 50400000000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 1006000000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 199061000000.0 |
| CurrentLiabilities | 157119000000.0 |
| EquityAttributableToOwnersOfParent | 271114000000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 117695000000.0 |